Dr Luke Milross Bethany Hunter Dr David McDonald George Merces Dr Amanda Thomson et al. | Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19 | 2024 |
|
Bethany Hunter Dr Ioana Nicorescu Emma Foster Dr David McDonald Dr Gill Hulme et al. | OPTIMAL: An OPTimized Imaging Mass cytometry AnaLysis framework for benchmarking segmentation and data exploration | 2024 |
|
Dr Luke Milross Bethany Hunter Dr Joaquim Majo Professor Andrew Filby Professor Andrew Fisher et al. | Downregulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19 | 2023 |
|
Dr Luke Milross Dr Joaquim Majo Bethany Hunter Professor Andrew Filby Professor Andrew Fisher et al. | Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients | 2023 |
|
Saskia Bos Dr Luke Milross Professor Andrew Filby Professor Andrew Fisher
| Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle | 2022 |
|
Dr Luke Milross Dr Joaquim Majo Bethany Hunter Dr Christopher Duncan Professor Andrew Filby et al. | The trajectory of COVID-19 cardiopulmonary disease: insights from an autopsy study of community-based, pre-hospital deaths | 2022 |
|
Dr Luke Milross Chelsea Griffiths Professor Andrew Fisher
| Ex Vivo Lung Perfusion: A Platform for Donor Lung Assessment, Treatment and Recovery | 2021 |
|